CoChat

MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

MicroRNAs are a recently discovered class of posttranscriptional regulators of gene expression with critical functions in health and disease. Psoriasis is the most prevalent chronic inflammatory skin disease in adults, with a substantial negative impact on the patients' quality of life. Here we show for the first time that psoriasis-affected skin has a specific microRNA expression profile when compared with healthy human skin or with another chronic inflammatory skin disease, atopic eczema. Among the psoriasis-specific microRNAs, we identified leukocyte-derived microRNAs and one keratinocyte-derived microRNA, miR-203. In a panel of 21 different human organs and tissues, miR-203 showed a highly skin-specific expression profile. Among the cellular constituents of the skin, it was exclusively expressed by keratinocytes. The up-regulation of miR-203 in psoriatic plaques was concurrent with the down-regulation of an evolutionary conserved target of miR-203, suppressor of cytokine signaling 3 (SOCS-3), which is involved in inflammatory responses and keratinocyte functions. Our results suggest that microRNA deregulation is involved in the pathogenesis of psoriasis and contributes to the dysfunction of the cross talk between resident and infiltrating cells. Taken together, a new layer of regulatory mechanisms is involved in the pathogenesis of chronic inflammatory skin diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0000610

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MicroRNA expression profiling in psoriasis, atopic eczema and healthy skin. (A) microRNA (miRNA) array comparison of skin from healthy individuals (H, n = 4) and lesional skin from patients with psoriasis (PSO, n = 3) and atopic eczema (AE, n = 3). Total RNA from skin biopsies was labeled and hybridized to microarrays containing probes corresponding to known miRNA sequences. The heat map summarizes the biological replicates for the skin specimens, and four technical replicates for each set. Color intensity is scaled within each row so that the highest expression value corresponds to bright red and the lowest to bright green. Gene names are listed to the right. (B) miRNAs showing more than 1.7-fold change between psoriasis and healthy skin (left) and atopic eczema and healthy skin (right) according to the SAM algorithm. miRNAs that are over-expressed in both psoriasis and in atopic eczema are highlighted in yellow, miRNAs that are down-regulated in both diseases are highlighted in blue. (C) The expressions of the functionally active, mature forms of four miRNAs were analyzed using quantitative real-time PCR in the skin of 26 healthy individuals, and lesional skin samples of 20 patients with atopic eczema and 25 patients with psoriasis. The results for individual patients and mean are shown. Data are expressed in relative units compared to U48 RNA. ***p<0.001, **p<0.01.
Figure 1 MicroRNA expression profiling in psoriasis, atopic eczema and healthy skin. (A) microRNA (miRNA) array comparison of skin from healthy individuals (H, n = 4) and lesional skin from patients with psoriasis (PSO, n = 3) and atopic eczema (AE, n = 3). Total RNA from skin biopsies was labeled and hybridized to microarrays containing probes corresponding to known miRNA sequences. The heat map summarizes the biological replicates for the skin specimens, and four technical replicates for each set. Color intensity is scaled within each row so that the highest expression value corresponds to bright red and the lowest to bright green. Gene names are listed to the right. (B) miRNAs showing more than 1.7-fold change between psoriasis and healthy skin (left) and atopic eczema and healthy skin (right) according to the SAM algorithm. miRNAs that are over-expressed in both psoriasis and in atopic eczema are highlighted in yellow, miRNAs that are down-regulated in both diseases are highlighted in blue. (C) The expressions of the functionally active, mature forms of four miRNAs were analyzed using quantitative real-time PCR in the skin of 26 healthy individuals, and lesional skin samples of 20 patients with atopic eczema and 25 patients with psoriasis. The results for individual patients and mean are shown. Data are expressed in relative units compared to U48 RNA. ***p<0.001, **p<0.01.CC BY · PubMed Central
Figure 2 Expression of miR-203, miR-146a, miR-21 and miR-125b in human organs. The expressions of the functionally active, mature forms of miR-203, miR-21, miR-146a and miR-125b were analyzed using quantitative real-time PCR in 20 healthy organs and tissues (each a pool of three donors) as well as in healthy skin (n = 26), lesional atopic eczema (n = 20) and psoriasis (n = 25) skin samples. Error bars represent the standard error of the mean. Data are expressed in relative units compared to U48 RNA. ***p<0.001, **p<0.01.
Figure 2 Expression of miR-203, miR-146a, miR-21 and miR-125b in human organs. The expressions of the functionally active, mature forms of miR-203, miR-21, miR-146a and miR-125b were analyzed using quantitative real-time PCR in 20 healthy organs and tissues (each a pool of three donors) as well as in healthy skin (n = 26), lesional atopic eczema (n = 20) and psoriasis (n = 25) skin samples. Error bars represent the standard error of the mean. Data are expressed in relative units compared to U48 RNA. ***p<0.001, **p<0.01.CC BY · PubMed Central
Figure 3 Expression of miR-203, miR-146a, miR-21 and miR-125b in the cellular constituents of the skin. The expressions of the functionally active, mature forms of miR-203, miR-146a, miR-21 and miR-125b were analyzed in the cellular constituents of the skin including primary adult keratinocytes, dermal fibroblasts, melanocytes, monocyte-derived dendritic cells (MDDCs), polymorphonuclear leukocytes (PMN), granulocytes, eosinophils, CD69+ cells, CD19+ cells, CD56+ cells, CD4+CD25high cells, CD8+ cells, CD4+ cells and mast cells using quantitative real-time PCR. Data are expressed in relative units compared to U48 RNA.
Figure 3 Expression of miR-203, miR-146a, miR-21 and miR-125b in the cellular constituents of the skin. The expressions of the functionally active, mature forms of miR-203, miR-146a, miR-21 and miR-125b were analyzed in the cellular constituents of the skin including primary adult keratinocytes, dermal fibroblasts, melanocytes, monocyte-derived dendritic cells (MDDCs), polymorphonuclear leukocytes (PMN), granulocytes, eosinophils, CD69+ cells, CD19+ cells, CD56+ cells, CD4+CD25high cells, CD8+ cells, CD4+ cells and mast cells using quantitative real-time PCR. Data are expressed in relative units compared to U48 RNA.CC BY · PubMed Central
Figure 4 SOCS-3 may be a molecular target of miR-203 posttranscriptional repression. (A) SOCS-3 is an evolutionarily conserved target of miR-203. The putative targets site of miR-203 is highly conserved among species. The 8mer seed sequence in the 3′UTR of SOCS-3 gene corresponding to miR-203 binding site is underlined. (B) In situ hybridization with LNA-oligonucleotide probes specific to miR-203 in skin sections from healthy skin and psoriatic lesional skin. Data are representative of 6 healthy and 6 psoriatic individuals. Note strong staining in the suprabasal layers of the epidermis in psoriatic skin. The expression of SOCS-3 in healthy and psoriasis skin samples was detected using immunohistochemistry. Original magnification 200x. (C) The expression of SOCS-3 in skin from healthy individuals or lesional skin of psoriatic patients was analyzed using Western blot analysis. SOCS-3 protein levels are expressed as relative units. Bars represent means of SOCS-3 protein levels in healthy skin (n = 6) and psoriatic lesional skin (n = 11) ± SEM. ** p<0.01.
Figure 4 SOCS-3 may be a molecular target of miR-203 posttranscriptional repression. (A) SOCS-3 is an evolutionarily conserved target of miR-203. The putative targets site of miR-203 is highly conserved among species. The 8mer seed sequence in the 3′UTR of SOCS-3 gene corresponding to miR-203 binding site is underlined. (B) In situ hybridization with LNA-oligonucleotide probes specific to miR-203 in skin sections from healthy skin and psoriatic lesional skin. Data are representative of 6 healthy and 6 psoriatic individuals. Note strong staining in the suprabasal layers of the epidermis in psoriatic skin. The expression of SOCS-3 in healthy and psoriasis skin samples was detected using immunohistochemistry. Original magnification 200x. (C) The expression of SOCS-3 in skin from healthy individuals or lesional skin of psoriatic patients was analyzed using Western blot analysis. SOCS-3 protein levels are expressed as relative units. Bars represent means of SOCS-3 protein levels in healthy skin (n = 6) and psoriatic lesional skin (n = 11) ± SEM. ** p<0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 767

Metadata

Authors
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., Ståhle, M., & Pivarcsi, A.
Affiliations
  • Karolinska Institutet (SE)
  • Finnish Institute of Occupational Health (FI)
  • Heinrich Heine University Düsseldorf (DE)
Corresponding author
  • Sonkoly, Enikö
  • Pivarcsi, Andor
Venue
PLoS ONE
Published
2007-07-11
Volume
2
Issue
7
Pages
e610
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1991320836
Cited by
754
References
24
Citations by year
2026: 6 · 2025: 18 · 2024: 19 · 2023: 29 · 2022: 37 · 2021: 45 · 2020: 44 · 2019: 35 · 2018: 30 · 2017: 39 · 2016: 67 · 2015: 55 · 2014: 64 · 2013: 50 · 2012: 50
FWCI
12.90
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Wenner-Gren Foundation
  • Insamlingsstiftelsen Cancer- och Allergifonden
  • Karolinska Institutet
  • Stockholms Läns Landsting
  • Szegedi Tudományegyetem
  • Medical Research Council
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
microRNA, psoriasis, miR-203, SOCS3, keratinocytes, miRNA expression profiling, atopic dermatitis, chronic inflammatory skin disease, post-transcriptional regulation, infiltrating immune cells
MeSH terms
Adult, Algorithms, Dermatitis, Atopic, Fibroblasts, Gene Expression Regulation, Humans, Mast Cells, Psoriasis, Quality of Life, Reference Values, Skin, Skin Physiological Phenomena, T-Lymphocytes, Blotting, Western, Keratinocytes, Gene Expression Profiling, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? https://app.cochat.ai/papers/10.1371/journal.pone.0000610
The paper
Sonkoly, E., Wei, T., Janson, P. C. J., Sääf, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., Scheynius, A., Ståhle, M., & Pivarcsi, A. (2007). MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? PLoS ONE. https://doi.org/10.1371/journal.pone.0000610

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.